Status:
COMPLETED
Neuropsychological Development and Executive Functioning of Children Born to HIV- Infected Mothers ( NEUROPSY-HEU )
Lead Sponsor:
Nantes University Hospital
Conditions:
HIV Infections
Exposure During Pregnancy
Eligibility:
All Genders
3-3 years
Phase:
NA
Brief Summary
Main objective: to evaluate the executive functioning of the HIV exposed uninfected children (HEU) versus children from the same socio-economic and cultural environment, not infected or affected by HI...
Detailed Description
The objective of the study is the exploration of executive functions (EF) and screening for neurodevelopment and learning disorders in children born to HIV-infected mothers, exposed to the virus and t...
Eligibility Criteria
Inclusion
- experimental:
- HIV-positive children born to mothers living with HIV antiretrovirals during pregnancy and in the neonatal period, aged 3 years +/- 3 months on the date of inclusion.
- Parents mastering the French.
- control:
- children, aged 3 years +/- 3 months on the date of inclusion, from the same socio-economic and cultural environment, no infected or affected by HIV.
- Parents mastering French.
Exclusion
- great prematurity (28-32 weeks)
- genetic anomaly
Key Trial Info
Start Date :
November 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 5 2024
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04108728
Start Date
November 19 2019
End Date
March 5 2024
Last Update
July 30 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Angers
Angers, France
2
Chd Vendee
La Roche-sur-Yon, France
3
Chu de Nantes
Nantes, France